Cargando…

Effects of Low-Dose Testosterone Undecanoate Treatment on Bone Mineral Density and Bone Turnover Markers in Elderly Male Osteoporosis with Low Serum Testosterone

This prospective 2-year, single-center, randomized, placebo-controlled, open-label clinical trial was performed to evaluate the efficacy of low-dose testosterone undecanoate (TU) treatment on bone mineral density (BMD) and biochemical markers of bone turnover in elderly male osteoporosis with low se...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yan-Jiao, Zhan, Jun-Kun, Huang, Wu, Wang, Yi, Liu, Yuan, Wang, Sha, Tan, Pan, Tang, Zhi-Yong, Liu, You-Shuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603196/ https://www.ncbi.nlm.nih.gov/pubmed/23533404 http://dx.doi.org/10.1155/2013/570413

Ejemplares similares

Effects of short-term testosterone replacement on areal bone mineral density and bone turnover in young hypogonadal males
por: Deb, Prasun, et al.
Publicado: (2012)

A New Oral Testosterone Undecanoate Formulation Restores Testosterone to Normal Concentrations in Hypogonadal Men
por: Swerdloff, Ronald S, et al.
Publicado: (2020)

Safety Aspects and Rational Use of Testosterone Undecanoate in the Treatment of Testosterone Deficiency: Clinical Insights
por: Campbell, Katherine, et al.
Publicado: (2023)

Effectiveness of a low dose testosterone undecanoate to improve sexual function in postmenopausal women
por: Tungmunsakulchai, Reuthairat, et al.
Publicado: (2015)

Oral testosterone undecanoate is an effective treatment for micropenis therapy
por: Saenger, Paul, et al.
Publicado: (2021)

Comparative application of testosterone undecanoate and/or testosterone propionate in induction of benign prostatic hyperplasia in Wistar rats
por: An, Jinho, et al.
Publicado: (2022)

Associations of LRP5 Gene With Bone Mineral Density, Bone Turnover Markers, and Fractures in the Elderly With Osteoporosis
por: Wang, Qi-Fei, et al.
Publicado: (2020)

Exploring the efficacy of testosterone undecanoate in male children with 5α‐reductase deficiency
por: Liu, Ying, et al.
Publicado: (2021)

Strawberry Decreases Intraluminal and Intestinal Wall Hydrolysis of Testosterone Undecanoate
por: Zgair, Atheer, et al.
Publicado: (2021)

Testosterone Replacement Therapy and Bone Mineral Density in Men with Hypogonadism
por: Kim, Se Hwa
Publicado: (2014)

Negative Association of Plasma Cholesterol and Low-density Lipoprotein Cholesterol, but not Testosterone or Growth Hormone, with Bone Mineral Density in Elderly Korean Men
por: SUNG, Dong Jun, et al.
Publicado: (2016)

Corrigendum for: “A New Oral Testosterone Undecanoate Formulation Restores Testosterone to Normal Concentrations in Hypogonadal Men”
Publicado: (2020)

Associations of IDUA and PTCH1 with Bone Mineral Density, Bone Turnover Markers, and Fractures in Chinese Elderly Patients with Osteoporosis
por: Wang, Qifei, et al.
Publicado: (2019)

Importance of measuring testosterone in enzyme-inhibited plasma for oral testosterone undecanoate androgen replacement therapy clinical trials
por: Lachance, Sylvain, et al.
Publicado: (2015)

Anaphylaxis Triggered by Benzyl Benzoate in a Preparation of Depot Testosterone Undecanoate
por: Ong, Gregory S. Y., et al.
Publicado: (2012)

Optimal injection interval for testosterone undecanoate treatment of hypogonadal and transgender men
por: Shankara Narayana, Nandini, et al.
Publicado: (2021)

Site-specific effect of testosterone on bone mineral density in male hypogonadism.
por: Choi, H. R., et al.
Publicado: (1995)

Testosterone Replacement and Bone Mineral Density in Male Pituitary Tumor Patients
por: Lee, Min Jeong, et al.
Publicado: (2014)

Suppression of spermatogenesis by testosterone undecanoate-loaded injectable in situ-forming implants in adult male rats
por: Zhang, Xiao-Wei, et al.
Publicado: (2016)

Effects of the oral testosterone undecanoate Kyzatrex™ on ambulatory blood pressure in hypogonadal men
por: White, William B., et al.
Publicado: (2021)

Effect of Testosterone Replacement Therapy on Bone Mineral Density in Patients with Klinefelter Syndrome
por: Jo, Dae Gi, et al.
Publicado: (2013)

Association of total testosterone status with bone mineral density in adults aged 40–60 years
por: Wang, Nan, et al.
Publicado: (2021)

Bone turnover in elderly men: relationships to change in bone mineral density
por: Nguyen, Tuan V, et al.
Publicado: (2007)

SAT-044 Treatment of Hypogonadal Men with a New Oral Testosterone Undecanoate (TU) Formulation Improves Psychosexual, Well-Being and Body Composition and Bone Density Parameters
por: Swerdloff, Ronald S, et al.
Publicado: (2020)

Interrelationships between sarcopenia, bone turnover markers and low bone mineral density in patients on hemodialysis
por: Wang, Yilin, et al.
Publicado: (2023)

Comparison of Effects of Alendronate and Raloxifene on Lumbar Bone Mineral Density, Bone Turnover, and Lipid Metabolism in Elderly Women with Osteoporosis
por: Iwamoto, Jun, et al.
Publicado: (2008)

SUN-234 Effect of Testosterone Undecanoate on Metabolic Syndrome Parameters in a Cohort of Hypogonadism
por: Yadav, Subhash Chandra, et al.
Publicado: (2019)

A new oral testosterone undecanoate therapy comes of age for the treatment of hypogonadal men
por: Swerdloff, Ronald S., et al.
Publicado: (2020)

Spectrophotometric and chromatographic strategies for exploring of the nanostructure pharmaceutical formulations which contains testosterone undecanoate
por: Butnariu, Monica, et al.
Publicado: (2020)

Recovery of Male Reproductive Endocrine Function Following Prolonged Injectable Testosterone Undecanoate Treatment
por: Shankara-Narayana, Nandini, et al.
Publicado: (2021)

Bioavailable Testosterone Is Positively Associated With Bone Mineral Density in Male Kidney Transplantation Candidates
por: Jørgensen, Hanne Skou, et al.
Publicado: (2018)

Effect of Denosumab on Bone Mineral Density and Markers of Bone Turnover among Postmenopausal Women with Osteoporosis
por: Sánchez, A., et al.
Publicado: (2016)

SUN-227 Monitoring Testosterone (T) Levels in Men Receiving Oral Testosterone Undecanoate (TU): Challenges Due to Post-Collection Conversion of TU-to-T and a Path Forward
por: Swerdloff, Ronald, et al.
Publicado: (2019)

Efficacy and Safety of Denosumab in Osteoporosis or Low Bone Mineral Density Postmenopausal Women
por: Chen, Yi, et al.
Publicado: (2021)

Occurrence of Pulmonary Oil Microembolism After Testosterone Undecanoate Injection: A Postmarketing Safety Analysis
por: Pastuszak, Alexander W., et al.
Publicado: (2020)

Characteristics of Bone Turnover in the Long Bone Metaphysis Fractured Patients with Normal or Low Bone Mineral Density (BMD)
por: Wölfl, Christoph, et al.
Publicado: (2014)

Pharmacological treatment for pubertal progression in boys with delayed or slow progression of puberty: A small-scale randomized study with testosterone enanthate and testosterone undecanoate treatment
por: Österbrand, Martin, et al.
Publicado: (2023)

Associated Factors of Bone Mineral Density and Osteoporosis in Elderly Males
por: Heidari, Behzad, et al.
Publicado: (2016)

3159 Bone Turnover Biomarkers May Discriminate Low Bone Mineral Density in HIV-Infected Adults
por: Collins, Lauren Frances, et al.
Publicado: (2019)

Effects of Five-Year Treatment with Testosterone Undecanoate on Metabolic and Hormonal Parameters in Ageing Men with Metabolic Syndrome
por: Francomano, Davide, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_lplm2so5rl41uf67u9calsvmap